A new theory of the mechanism of percutaneous arterial angioplasty is advanced. For this study, abdominal aortas and coronary, renal, superior mesenteric, and iliac arteries were obtained from cadavers. In addition, the iliac arteries of dogs were dilated and studied. No evidence of significant compression or redistribution of plaques could be found, supporting the theory that atheromatous material is incompressible. Cracking of the intima and separation of it from the media were histologically demonstrated following angioplasty. It is proposed that the stretched media distends following dilatation, carrying with the intima and atheromatous material. Once the media is freed from the encasing effect of the intima, it adapts to the circulatory needs of the body. Beyond a certain point, the arterial widening becomes permanent, due to an overstretching of the muscle fibers, which is demonstrated by a corkscrew deformity of the muscle cell nuclei.
Abnormal systemic-to-pulmonary-artery anastomoses can exist in many pathological conditions and result in a left-to-right shunt. Three such conditions are (a) congenital abnormalities, e.g., pulmonary vein atresia, (b) acquired states, e.g., chronic bronchiectasis, and (c) post-surgical states, e.g., a Mustard procedure for complete transposition. Regardless of the etiology, the anastomosis and resulting shunt produce increased oxygen saturation in the ipsilateral pulmonary artery. Four cases are presented, with emphasis on the angiographic and hemodynamic findings.
These results are comparable to those for other forms of treatment of ascites. The authors do not, however, recommend TIPS in patients with a Child-Pugh score greater than 11.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.